The Effect of Intravenous Tranexamic Acid on Perioperative Blood Loss, Transfusion Requirements, Verticalization, and Ambulation in Total Knee Arthroplasty: A Randomized Double-Blind Study
- PMID: 39064612
- PMCID: PMC11279079
- DOI: 10.3390/medicina60071183
The Effect of Intravenous Tranexamic Acid on Perioperative Blood Loss, Transfusion Requirements, Verticalization, and Ambulation in Total Knee Arthroplasty: A Randomized Double-Blind Study
Abstract
Background and Objectives: Total knee arthroplasty (TKA) is sometimes associated with significant perioperative bleeding. The aim of this study was to determine the efficacy of tranexamic acid (TXA) in reducing perioperative blood loss in patients undergoing primary TKA. The secondary objectives were to assess the efficacy of TXA in reducing the need for blood transfusion in these patients and to determine its effect on verticalization and ambulation after TKA. Materials and Methods: This study included 96 patients who were randomly assigned to two groups, each containing 48 patients. The study group received intravenous TXA at two time points: immediately after the induction with doses of 15 mg/kg and 10 mg/kg 15 min before the release of the pneumatic tourniquet. The control group received an equivalent volume of 0.9% saline solution via the same route. Results: TXA markedly reduced (Z = -6.512, p < 0.001) the total perioperative blood loss from 892.56 ± 324.46 mL, median 800 mL, interquartile range (IQR) 530 mL in the control group, to 411.96 ± 172.74 mL, median 375 mL, IQR 200 mL, in the TXA group. In the TXA group, only 5 (10.4%) patients received a transfusion, while in the control group, 22 (45.83%) received it (χ2 = 15.536, p = 0.001). Patients in the study group stood (χ2 = 21.162, p < 0.001) and ambulated earlier postoperatively, compared to the control group (χ2 = 26.274, p < 0.001). Patients who received TXA had a better overall postoperative functional recovery. There was a statistically significant difference in all the above results. Conclusions: TXA is an effective drug for reducing the incidence of perioperative bleeding, decreasing transfusion rates, and indirectly improving postoperative functional recovery in patients undergoing primary TKA.
Keywords: ambulation; perioperative bleeding; total knee arthroplasty; tranexamic acid; transfusion; verticalization.
Conflict of interest statement
The authors declare no conflicts of interest.
Figures



Similar articles
-
Tranexamic acid or epsilon-aminocaproic acid in total joint arthroplasty? A randomized controlled trial.Bone Joint J. 2019 Sep;101-B(9):1093-1099. doi: 10.1302/0301-620X.101B9.BJJ-2018-1096.R1. Bone Joint J. 2019. PMID: 31474134 Clinical Trial.
-
One Dose of Intravenous Tranexamic Acid Is Equivalent to Two Doses in Total Hip and Knee Arthroplasty.J Bone Joint Surg Am. 2018 Jul 5;100(13):1104-1109. doi: 10.2106/JBJS.17.00641. J Bone Joint Surg Am. 2018. PMID: 29975264
-
Intravenous and subsequent long-term oral tranexamic acid in enhanced-recovery primary total knee arthroplasty without the application of a tourniquet: a randomized placebo-controlled trial.BMC Musculoskelet Disord. 2019 Oct 25;20(1):478. doi: 10.1186/s12891-019-2885-5. BMC Musculoskelet Disord. 2019. PMID: 31653221 Free PMC article. Clinical Trial.
-
The efficacy and safety of combined administration of intravenous and topical tranexamic acid in primary total knee arthroplasty: a meta-analysis of randomized controlled trials.BMC Musculoskelet Disord. 2018 Sep 7;19(1):321. doi: 10.1186/s12891-018-2181-9. BMC Musculoskelet Disord. 2018. PMID: 30193586 Free PMC article. Review.
-
Oral vs intravenous tranexamic acid in total-knee arthroplasty and total hip arthroplasty: A systematic review and meta-analysis.Medicine (Baltimore). 2019 May;98(20):e15248. doi: 10.1097/MD.0000000000015248. Medicine (Baltimore). 2019. PMID: 31096433 Free PMC article.
Cited by
-
Does Multiple Intravenous Tranexamic Acid Doses in Patients Undergoing Total Knee Arthroplasty using Kinematic Alignment without Tourniquet Application show any Difference in Blood Loss, Transfusion Requirements and Hospital Stays: A Randomized Controlled Study.J Orthop Case Rep. 2025 Mar;15(3):281-288. doi: 10.13107/jocr.2025.v15.i03.5412. J Orthop Case Rep. 2025. PMID: 40092277 Free PMC article.
References
-
- Wu Q., Zhang H.A., Liu S.L., Meng T., Zhou X., Wang P. Is tranexamic acid clinically effective and safe to prevent blood loss in total knee arthroplasty? A meta-analysis of 34 randomized controlled trials. Eur. J. Orthop. Surg. Traumatol. 2015;25:525–541. doi: 10.1007/s00590-014-1568-z. - DOI - PubMed
-
- Fu D., Chen C., Guo L., Yang L. Use of intravenous tranexamic acid in total knee arthroplasty: A meta-analysis of randomized controlled trials. Chin. J. Traumatol—Engl. Ed. 2013;16:67–76. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical